Risk factors for severe respiratory syncytial virus‐associated lower respiratory tract infection in children
- 5 October 2001
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 43 (5) , 489-492
- https://doi.org/10.1046/j.1442-200x.2001.01438.x
Abstract
Background : Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract infection that can be a life‐threatening disease in infants and children. This study was conducted to look for independent risk factors for severe respiratory syncytial virus‐associated lower respiratory tract infection (RSV‐LRI) that required oxygen supplementation or mechanical ventilation. Methods : Medical records of patients younger than 4 years hospitalized with RSV‐LRI at Shizuoka Red Cross Hospital from July 1, 1995 to June 30, 1999 were reviewed. The patients were compared using univariate and multivariate logistic regression analysis. Results : A total of 157 patients were hospitalized with RSV‐LRI at Shizuoka Red Cross Hospital from the study time period. Of these, 20 patients (12.7%) were diagnosed with severe RSV‐LRI. Subjects younger than 3 months of age had an odds ratio (OR) of 59.9 (95% confidence interval (CI) 14.7_244.0) for the dependent variable of severe RSV‐LRI (PP Conclusions : Infants younger than 3 months without any underlying diseases may be at high risk for severe RSV‐LRI. Respiratory syncytial virus prophylaxis is needed not only for high‐risk patients, but for healthy early infants.Keywords
This publication has 13 references indexed in Scilit:
- Severe Respiratory Syncytial Virus Disease in Alaska Native ChildrenThe Journal of Infectious Diseases, 1999
- Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIVPediatrics, 1998
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Risk factors for respiratory syncytial virus associated apnoeaEuropean Journal of Pediatrics, 1998
- Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV InfectionsPublished by American Academy of Pediatrics (AAP) ,1997
- Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infectionThe Journal of Pediatrics, 1995
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993
- Risk factors for mechanical ventilation in respiratory syncytial virus infectionEuropean Journal of Pediatrics, 1993
- EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN WASHINGTON, D.C.American Journal of Epidemiology, 1973
- Clinical Significance of Respiratory Syncytial VirusPostgraduate Medicine, 1964